Kinetics of Immune Responses Elicited after Three mRNA COVID-19 Vaccine Doses in Predominantly Antibody-Deficient Individuals

Researchers evaluated the immune responses developed in SARS-CoV-2-uninfected patients with predominantly antibody-deficiencies after three mRNA-1273 vaccine doses.